Education
About Us
Working with TipRanks
Follow Us
AptarGroup (ATR)
NYSE:ATR
ATR Stock Chart & Stats
$123.63
-$0.05(-0.03%)
At close: 4:00 PM EST
$123.63
-$0.05(-0.03%)
Day’s Range― - ―
52-Week Range$103.23 - $164.28
Previous CloseN/A
Volume34.64K
Average Volume (3M)580.43K
Market Cap
$8.06B
Enterprise Value$9.93B
Total Cash (Recent Filing)$264.81M
Total Debt (Recent Filing)$931.72M
Price to Earnings (P/E)19.7
Beta0.55
Next Earnings
Feb 12, 2026EPS Estimate
1.24Next Dividend Ex-DateN/A
Dividend Yield1.49%
Share Statistics
EPS (TTM)1.62
Shares Outstanding65,619,156
10 Day Avg. Volume593,919
30 Day Avg. Volume580,435
Financial Highlights & Ratios
PEG Ratio0.92
Price to Book (P/B)4.22
Price to Sales (P/S)2.91
P/FCF Ratio29.84
Enterprise Value/Market Cap1.23
Enterprise Value/Revenue2.71
Enterprise Value/Gross Profit7.94
Enterprise Value/Ebitda11.81
Forecast
1Y Price Target
$152.00Price Target Upside22.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
EPS Forecast (FY)5.72
Revenue Forecast (FY)$3.69B
Bulls Say, Bears Say
Bulls Say
Business Expansion StrategyThe acquisition aligns with Aptar's strategy of expanding its Pharma business through small, bolt-on acquisitions.
Financial PerformanceThe company delivered its 10th consecutive EBITDA beat and 13th straight EPS beat.
Strategic AcquisitionsThe acquisition of Sommaplast strengthens Aptar's presence in the Latin American region.
Bears Say
Growth And Margin ChallengesNarcan headwind is expected to persist, creating a challenging growth and margin outlook.
Market ExpectationsFourth-quarter EPS guidance was well below consensus expectations.
Revenue And Profitability ConcernsThe initial revenue and profitability contribution from Sommaplast is expected to be minimal.
AptarGroup News
ATR FAQ
What was AptarGroup’s price range in the past 12 months?
AptarGroup lowest stock price was $103.23 and its highest was $164.28 in the past 12 months.
What is AptarGroup’s market cap?
AptarGroup’s market cap is $8.06B.
When is AptarGroup’s upcoming earnings report date?
AptarGroup’s upcoming earnings report date is Feb 12, 2026 which is in 55 days.
How were AptarGroup’s earnings last quarter?
AptarGroup released its earnings results on Oct 30, 2025. The company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.567 by $0.053.
Is AptarGroup overvalued?
According to Wall Street analysts AptarGroup’s price is currently Undervalued.
Does AptarGroup pay dividends?
AptarGroup pays a Quarterly dividend of $0.48 which represents an annual dividend yield of 1.49%. See more information on AptarGroup dividends here
What is AptarGroup’s EPS estimate?
AptarGroup’s EPS estimate is 1.24.
How many shares outstanding does AptarGroup have?
AptarGroup has 65,619,156 shares outstanding.
What happened to AptarGroup’s price movement after its last earnings report?
AptarGroup reported an EPS of $1.62 in its last earnings report, beating expectations of $1.567. Following the earnings report the stock price went down -6.714%.
Which hedge fund is a major shareholder of AptarGroup?
Currently, no hedge funds are holding shares in ATR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AptarGroup Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$152.00 (22.95% Upside)
$152.00 (22.95% Upside)
Blogger Sentiment
Bullish
ATR Sentiment 75%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 18.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 7.6%
Last 30 Days ▲ 32.0%
Last 30 Days ▲ 32.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.25%
12-Months-Change
Fundamentals
Return on Equity
15.80%
Trailing 12-Months
Asset Growth
10.28%
Trailing 12-Months
Company Description
AptarGroup
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
ATR Company Deck
ATR Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Aptar's earnings call presented a mixed outlook. The company highlighted growth in its Pharma segment, strategic acquisitions, and shareholder returns. However, challenges in the emergency medicine market and segments like Beauty and Closures, along with atypical litigation costs, were notable lowlights.View all ATR earnings summariesATR Stock 12 Month Forecast
Average Price Target
$152.00
▲(22.95% Upside)
Technical Analysis
Baxter International
―
Cooper Co
―
Repligen
―
West Pharmaceutical Services
―
Stevanato Group
―
Ownership Overview
0.64% Insiders
31.59% Mutual Funds
28.14% Other Institutional Investors
15.48% Public Companies and
Individual Investors